Description |
adenylate cyclase 2 |
adenylate cyclase 1 |
Image |
No pdb structure |
No pdb structure |
GO Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
|
Diseases |
|
|
GWAS |
- Anxiety and stress-related disorders ( 31116379)
- Atorvastatin-induced myopathy ( 31220337)
- Bipolar disorder ( 24618891 31043756)
- Bipolar disorder (age of onset <21) or attention deficit hyperactivity disorder ( 27890468)
- Bipolar disorder or attention deficit hyperactivity disorder ( 27890468)
- Bipolar I disorder ( 31043756)
- Capecitabine sensitivity ( 22864933)
- Coffee consumption ( 31046077)
- Cognitive decline rate in late mild cognitive impairment ( 26252872)
- Food addiction ( 27106561)
- Mean arterial pressure (alcohol consumption interaction) ( 24376456)
- Oropharynx cancer ( 27749845)
- Pars opercularis volume ( 31530798)
- Plasma factor VII activating protease levels ( 30070759)
- Posterior-cingulate cortex volume ( 31530798)
- Smoking status (heavy vs never) ( 26423011)
- Visceral fat ( 22589738)
|
- Bipolar disorder lithium response (continuous) or schizophrenia ( 29121268)
- Night sleep phenotypes ( 27126917)
- Subjective response to lithium treatment in bipolar disorder ( 26503763)
|
Interacting Genes |
3 interacting genes:
ADCY1
ADCY5
GNAS
|
3 interacting genes:
ADCY2
GNAI2
SERTAD1
|
Entrez ID |
108 |
107 |
HPRD ID |
00052 |
00053 |
Ensembl ID |
ENSG00000078295
|
ENSG00000164742
|
Uniprot IDs |
Q08462
Q71UM8
|
C9J1J0
Q08828
|
PDB IDs |
|
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|